Sanuwave Health (SNWV) Stock Statistics & Valuation Metrics

Sanuwave Health has a market cap or net worth of $280.70M. The enterprise value is $357.44M.

Sanuwave Health has 8,576,164 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sanuwave Health’s return on equity (ROE) is 2.47 and return on invested capital (ROIC) is 41.45%.

The current PE Ratio of Sanuwave Health is ―. Sanuwave Health’s PEG ratio is 0.08.

In the last 12 months, Sanuwave Health had revenue of 32.63M and earned -31.37M in profits. Earnings per share was -7.03.

In the last 12 months, operating cash flow was 1.30M and capital expenditures -2.08M, giving a free cash flow of -784.00K billion.

Sanuwave Health pays an annual dividend of ―, resulting in a dividend yield of ―

Sanuwave Health upcoming earnings date is Apr 7, 2026, TBA (Confirmed).

Sanuwave Health as a current ratio of 0.43, with Debt / Equity ratio of -229.17%

In the past 12 months, Sanuwave Health has paid 27.00K in taxes.

Sanuwave Health EV to EBITDA ratio is -7.12, with an EV/FCF ratio of 60.00.

Sanuwave Health has $9.60M in cash and marketable securities with $24.45M in debt, giving a net cash position of -$14.85M billion.

Gross margin is 78.26%, with operating margin of 16.60%, and net profit margin of -96.13%.

The average price target for Sanuwave Health is $53.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy